# GSK reports on a US court ruling in ongoing litigation.

*biotech · news · 2026-04-27 · MarketScreener*

## Key points

- GSK's Tesaro had its anticipatory breach claim dismissed, but its main dispute with AnaptysBio continues.
- AstraZeneca's Saphnelo is now FDA-approved in the US for self-administration via autoinjector in lupus treatment.
- Harworth Group secured planning approval for a 500,000-square-foot Microsoft-linked hyperscale data centre in Leeds.
- Kelso Group now holds a new stake in Filtronic, which has tripled revenue and 90% of FY2026 covered.

**Companies:** AstraZeneca, GSK, Harworth Group, Molten Ventures, Filtronic
**Countries:** United States, United Kingdom

[Read the full story on MarketScreener](https://www.marketscreener.com/news/astrazeneca-wins-us-drug-nod-gsk-in-court-ruling-ce7f59dcdc8df127)

---

Canonical: https://newsio.io/n/9a04eab0-db7d-48a7-97f2-084501beacc2/gsk-reports-on-a-us-court-ruling-in-ongoing-litigation-astrazeneca-announces-us
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works